Tweet
<img alt="" height="1" width="1" />
Pioglitazone Gets New Cancer Risk Labeling
MedPage Today
The FDA has approved updated label information for pioglitazone (Actos) and medications that contain it, following its warning in June about bladder cancer risk with the drug. ...
Lawsuits follow diabetes drug link to cancer riskSan Francisco Chronicle
FDA Adds Bladder Cancer Risk Warning to PioglitazoneFamily Practice News Digital Network
New pioglitazone label highlights bladder-cancer riskTheHeart.Org
Endocrine Today -Bioscience Technology
all 23 news articles »
More...